Impact of the initiation of flash glucose monitoring (FGM) on glycemic control parameters in adult patients with type 2 diabetes mellitus.
The effective implementation of the FGM contributes to achieving glycemic control, reducing hypoglycemic and hyperglycemic decompensations as well as enhancing patient self-management and improving their perception of quality of life. The aim of our study was to evaluate the glycemic control in type 2 diabetes patients after having implemented FGM in clinical practice.
Current patients with type 2 diabetes treated in our unit were monitored (FGM). A Structured Therapeutic Education Program was carried out and glycemic control variables were compared at the start and after 3 months of treatment.
A total of 36 patients were included (mean age of 67.8±12.4 years, 36.11% female, diabetes duration 21.5±2.12 years and a previous median glycated hemoglobine of 7.55%). Comparing the baseline data and the measures at 3 months, it was found a decrease in both glucose management indicator (GMI) (0.15% [0.40;0.30], P 0,537) and the coefficient of variation (CV) (1,42±4,66%, P 0,07), as well as an increase in time in range (TIR) (3,44±14.72%, P 0,169). Furthermore, a decrease in time in hyperglycemia >250mg/dl was observed (2,00% [-6,50;0,00] P 0,001).
FGM has led to a favorable advance in the management and glycemic control in patients with type 2 diabetes.
Current patients with type 2 diabetes treated in our unit were monitored (FGM). A Structured Therapeutic Education Program was carried out and glycemic control variables were compared at the start and after 3 months of treatment.
A total of 36 patients were included (mean age of 67.8±12.4 years, 36.11% female, diabetes duration 21.5±2.12 years and a previous median glycated hemoglobine of 7.55%). Comparing the baseline data and the measures at 3 months, it was found a decrease in both glucose management indicator (GMI) (0.15% [0.40;0.30], P 0,537) and the coefficient of variation (CV) (1,42±4,66%, P 0,07), as well as an increase in time in range (TIR) (3,44±14.72%, P 0,169). Furthermore, a decrease in time in hyperglycemia >250mg/dl was observed (2,00% [-6,50;0,00] P 0,001).
FGM has led to a favorable advance in the management and glycemic control in patients with type 2 diabetes.
Authors
Manrique Mutiozábal Manrique Mutiozábal, Legarreta Alday Legarreta Alday, Alba Muñoz Alba Muñoz, Sánchez Uribe Sánchez Uribe, Deusto Puertas Deusto Puertas, Zorrozúa Borja Zorrozúa Borja, Antuñano López Antuñano López, Ruiz de Azúa Arteche Ruiz de Azúa Arteche, Benito Martínez Benito Martínez, Caballero Renilla Caballero Renilla, Guimón Bardesi Guimón Bardesi
View on Pubmed